ERAS-0015 Phase 1 data, valuation gap, Merck deal, funding, and key risks like patents. Click for more on ERAS stock.

Agenus (AGEN) is back in focus after reporting three year Phase 1b data for its BOT+BAL immunotherapy in refractory ...

Detroit Free Press web editor Elissa Beth Robinson died July 14 of colorectal cancer, surviving more than five years after ...

Scientists at National Taiwan University College of Medicine have discovered that cancer formation is not simply caused by ...

Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, ...

By DEVI SHASTRI and MARY CONLON More people are focusing on their gut health, as fibermaxxing goes mainstream, colorectal ...

AgenusInc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three abstracts from investigator-sponsored trials evaluating botensilimab and balstilimab (BOT+BAL) have been ...

There are several evidence-based lifestyle and diet changes you can make right now to support your gut. For example, eating ...

New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment.

After launching an organized CRC screening program in Hong Kong, socioeconomic disparities have narrowed but persist among certain groups.

Most people don't celebrate Labor Day by hopping on a bicycle and riding across Montana. But that's exactly what Great Falls ...